Symposium "Invest in the future: defeat malaria" in London
15 April 2015
To mark World Malaria Day, the ACT Consortium is convening a group of experts to discuss important aspects of malaria control at the London School of Hygiene & Tropical Medicine.
Date: Thursday 23 April 2015
Time: 5:30 pm - 7:00 pm BST
Venue: John Snow Lecture Theatre, LSHTM, Keppel Street, London, WC1E 7HT, UK
Type of event: Seminar
Please register for the event here
The event will also be live streamed
Twitter: #WMDLondon
Malaria is a preventable and treatable mosquito-borne illness. Between 2000 and 2013, an expansion of interventions helped to reduce malaria mortality rates worldwide by 47% and by 54% in the WHO African Region, where most malaria deaths occur.
SPEAKERS
1. Malaria rapid diagnostic tests (RDTs) in action: targeting treatment to those who need it
David Schellenberg
Director, ACT Consortium and Professor of Malaria & International Health, LSHTM
The ACT Consortium has delivered 25 studies in 10 countries to answer key questions on malaria drug delivery. David will present research outcomes and challenges from different interventions to introduce RDTs in the public and private health sectors.
2. Antimalarial medicines: how effective are they for vulnerable groups?
Christian Nsanzabana
Scientific coordinator, WorldWide Antimalarial Resistance Network (WWARN)
Christian will share recent results on how large scale pooled analysis of data sets from different clinical trials in Asia and Africa has provided the malaria research community with potentially life-saving insights into the potential impact of different dosing regimens and treatment approaches for small children.3. Making best use of imperfect malaria vaccines
Brian Greenwood
Professor of Clinical Tropical Medicine, LSHTM and Investigator in phase 3 trial of malaria vaccine RTS,S/AS01
It is unlikely that the first generation of malaria vaccines will provide more than partial protection against malaria. Brian Greenwood will discuss some of the ways in which such vaccines might be used.
4. Global Call to Action to increase national coverage of intermittent preventive treatment of malaria in pregnancy
Matthew Chico
Lecturer, LSHTM
The intermittent preventive treatment against malaria in pregnancy (IPTp) is a highly cost-effective intervention with the potential to save many maternal and neonatal lives. However, coverage remains low in sub-Saharan Africa where an estimated 15 million pregnant women in 2013 did not receive a single dose of IPTp. The Global Call to Action provides a roadmap for stakeholders to overcome barriers to IPTp uptake.
5. Global Resource Mobilisation For Malaria: The Next Chapter
James Whiting
Executive Director, Malaria No More UK
This summer, the follow up to the Roll Back Malaria Partnership's Global Malaria Action Plan (GMAP2) is being launched. James, who sits on the Steering Group, will discuss the new global malaria targets as well as the resources needed to meet them.
CHAIR
Catherine Goodman
Deputy Director of the Malaria Centre and Reader in Health Economics and Policy, LSHTM
Admission: Registration required, please click here.